Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
BBLG is expected to report earnings to rise 2.63% to -38 cents per share on September 02
Q2'26
Est.
$-0.39
Q4'25
Beat
by $6.98
Q3'25
Beat
by $7.55
Q2'25
Beat
by $6.51
Q1'25
Beat
by $7.36
The last earnings report on March 02 showed earnings per share of -37 cents, beating the estimate of -736 cents. With 10.87K shares outstanding, the current market capitalization sits at 2.46M.